Dr. Salwa E. Gomaa is currently a postdoctoral researcher at the School of Basic Medical Sciences, Henan University, China. She is also an academic lecturer at the Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University, Egypt. Dr. Gomaa’s current research areas involve isolation and biologic/genome characterization of a wide range of bacteriophages. Her work also includes investigating phage-antibiotic synergy against several clinically relevant pathogens, including E. faecalis, S. dysenteriae, and K. pneumoniae. She studies phage anti-biofilm activity, the emergence of phage resistance, and the associated bacterial fitness trade-offs across different pathogens. In parallel, she has extensive experience in isolating, handling, and preserving pathogenic bacteria. Her research interests further extend to anti-virulence strategies and efflux pump inhibition. Moreover, she is experienced in multiple infection models, including mouse models (systemic, vaginal, and wound infections), the Galleria mellonella infection model, and the ex vivo porcine lung infection model, to evaluate bacterial pathogenicity and phage therapeutic efficacy. Dr. Gomaa has a strong publication record, with her research outcomes published in leading high-impact, peer-reviewed journals.
Dr. Salwa E. Gomaa is currently a postdoctoral researcher at the School of Basic Medical Sciences, Henan University, China. She is also an academic lecturer at the Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University, Egypt. Dr. Gomaa’s current research areas involve isolation and biologic/genome characterization of a wide range of bacteriophages. Her work also includes investigating phage-antibiotic synergy against several clinically relevant pathogens, including E. faecalis, S. dysenteriae, and K. pneumoniae. She studies phage anti-biofilm activity, the emergence of phage resistance, and the associated bacterial fitness trade-offs across different pathogens. In parallel, she has extensive experience in isolating, handling, and preserving pathogenic bacteria. Her research interests further extend to anti-virulence strategies and efflux pump inhibition. Moreover, she is experienced in multiple infection models, including mouse models (systemic, vaginal, and wound infections), the Galleria mellonella infection model, and the ex vivo porcine lung infection model, to evaluate bacterial pathogenicity and phage therapeutic efficacy. Dr. Gomaa has a strong publication record, with her research outcomes published in leading high-impact, peer-reviewed journals.